Results 171 to 180 of about 53,405 (189)
Some of the next articles are maybe not open access.

Imatinib Mesylate

2017
openaire   +1 more source

Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice

Modern Rheumatology, 2007
Masanori Wako   +2 more
exaly  

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

Journal of Clinical Oncology, 2008
C. Blanke   +15 more
semanticscholar   +1 more source

c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571)

Cancer Chemotherapy and Pharmacology, 2002
Marc Hotfilder   +2 more
exaly  

Cost-utility analysis of imatinib mesylate for the treatment ofchronic myelogenous leukemia in the chronic phase

Clinical Therapeutics, 2004
Paul Scuffham, Sue Ward
exaly  

Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma

Clinical and Experimental Metastasis, 2014
A. Calipel   +6 more
semanticscholar   +1 more source

Combined treatment of 3-hydroxyflavone and imatinib mesylate increases apoptotic cell death of imatinib mesylate-resistant leukemia cells

Leukemia Research, 2012
Jung-Hyun Kim   +2 more
exaly  

Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment

Leukemia and Lymphoma, 2006
K Takeyama, H Ohira
exaly  

Antitumor activity of imatinib mesylate in neuroblastoma xenografts

Cancer Letters, 2005
, Tiziana Servidei, Daniela Meco
exaly  

Imatinib mesylate in the treatment of chronic myeloid leukaemia

Expert Opinion on Pharmacotherapy, 2003
Brian Druker
exaly  
antineoplastic agents
pyrimidines
benzamides
chemistry
piperazines
humans
3. good health
chronic myeloid leukemia
imatinib
previous   16  17  18  19  

Home - About - Disclaimer - Privacy